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ABSTRACT
We present a deep learning framework for computer-aided lung
cancer diagnosis. Our multi-stage framework detects nodules in 3D
lung CAT scans, determines if each nodule is malignant, and nally
assigns a cancer probability based on these results. We discuss the
challenges and advantages of our framework. In the Kaggle Data
Science Bowl 2017, our framework ranked 41st out of 1972 teams.
CCS CONCEPTS
•Computingmethodologies→Object detection; Object recog-
nition; Neural networks; •Applied computing→ Health in-
formatics;
KEYWORDS
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1 INTRODUCTION
Cancer is one of the leading causes of death worldwide, with lung
cancer being among the leading cause of cancer related death. In
2012, it was estimated that 1.6 million deaths were caused by lung
cancer, while an additional 1.8 million new cases were diagnosed
[32].
Screening for lung cancer is crucial in the early diagnosis and
treatment of patients, with beer screening techniques leading
to improved patient outcome. e National Lung Screening Trial
found that screening with the use of low-dose helical computed to-
mography (CT) reduced mortality rates by 20% compared to single
view radiography in high-risk demographics [31]. However, screen-
ing for lung cancer is prone to false positives, increasing costs
through unnecessary treatment and causing unnecessary stress
∗Authors contributed equally to this work.
†Corresponding authors.
for patients [10]. Computer-aided diagnosis of lung cancer oers
increased coverage in early cancer screening and a reduced false
positive rate in diagnosis.
e Kaggle Data Science Bowl 2017 (KDSB17) challenge was held
from January to April 2017 with the goal of creating an automated
solution to the problem of lung cancer diagnosis from CT scan
images [16]. In this work, we present our solution to this challenge,
which uses 3D deep convolutional neural networks for automated
diagnosis.
1.1 Related Work
Computer-aided diagnosis (CAD) is able to assist doctors in under-
standing medical images, allowing for cancer diagnosis with greater
sensitivity and specicity, which is critical for patients. Demir and
Yener [8] survey CAD pipelines, separating them into preprocess-
ing, feature extraction, selection, and nally classication. ey
further document the use of logistic regression, decision trees, k-
nearest neighbour, and neural networks in existing approaches.
Khalvati et al. [18] use an SVM over MRI scan texture features to
detect prostate cancer in patients. e winners of the Camelyon16
challenge [1], for example, detect breast cancer from images of
lymph nodes.
Deep convolutional neural networks (CNN) have proven to per-
form well in image classication [14, 20, 30], object detection [27],
and other visual tasks. ey have found great success in medical
imaging applications [17], and are for example able to detect skin
cancer metastases [34], achieving substantially beer sensitivity
performance than human pathologists. ese methods all operate
on two-dimensional images, typically a cross-sectional image of
the aected body part.
In comparison, CT image scans are three-dimensional volumes
and are usually anisotropic. Deep networks have also been shown
to perform well in 3D segmentation [23], and have been successfully
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adapted from 2D to 3D [6, 12]. Liao et al. [22] have demonstrated
a 3D deep learning framework to perform automatic prostate seg-
mentation. Kumar et al. [21] perform the segmentation and classi-
cation of lung cancer nodules separately.
e LUNA16 challenge [29] had two tasks: detecting pulmonary
nodules using CT scans, and reducing the false positive rate from
identifying these nodules. e former was solved by Moira et al.
[24] using UNet [28] on stacks of 3 consecutive horizontal lung
slices; and the laer was won by Dou et al. [9] by applying multi-
contextual 3D CNNs.
e top two teams in the Kaggle Data Science Bowl 2017 have
published their solutions to the challenge [7, 11]. Both teams pro-
ceed to an intermediate step before giving patients a cancer prob-
ability. Aer having identied regions of possible abnormalities
(nodules), the team placing second, de Wit [7], uses 17 dierent 3D
CNNs to extract medically relevant features about nodules. en,
they aggregate the predictions of these nodules aributes into a
patient-level descriptor. e team placing rst [11] detects nodules
via a 3D CNN, then uses the highest condence detections as well
as manual nodule labelling to predict cancer via a simple classier.
1.2 Key Challenges
One key characteristic of lung cancer is the presence of pulmonary
nodules, solid clumps of tissue that appear in and around the lungs
[2]. ese nodules are visible in CT scan images and can be ma-
lignant (cancerous) in nature, or benign (not cancerous). In cancer
screening, radiologists and oncologists examine CT scans of the
lung volume to identify nodules and recommend further action:
monitoring, blood tests, biopsy, etc. Specically, lung cancer is
screened through the presence of nodules [2, 3].
To build a system for computer-aided diagnosis (CAD) of lung
cancer, we investigate the following approaches:
(1) A single-stage network that automatically learns cancer
features and produces a cancer probability directly from
CT scan images of patients.
(2) A multi-stage framework that rst localizes nodules, clas-
sies the malignancy of each one, and nally produces a
cancer probability of patients.
In our initial experiments however, the single-stage network,
implemented as a 3D CNN, fails to converge across a wide set
of hyperparameters, performing only slightly beer than random
chance.
Factoring the problem into multiple stages on the other hand
signicantly improves convergence. Even when the single-stage
network fails to converge in training, each stage of our pipeline
can be easily trained to convergence, as illustrated in Figure 1.
Our framework as detailed in this work therefore focuses on a
multi-stage pipeline, focusing on detection and classication of
pulmonary nodules.
is approach presents the following problems: the shape and
size of nodules vary, and benign nodules can look very similar to
malignant ones. Furthermore, the presence of blood vessels in the
lung makes distinguishing nodules a challenging task, especially
on 2D image slices. is makes the task more suitable for 3D CNNs
which are beer able to identify nodules based on their structure
in 3D space.
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Figure 1: Top: Training loss of single-stage network, which
fails to converge.
Bottom: Training loss of malignancy detector in the multi-
stage framework, which easily converges.
2 TECHNICAL APPROACH
2.1 Data
While the Kaggle Data Science Bowl 2017 (KDSB17) dataset provides
CT scan images of patients, as well as their cancer status, it does not
provide the locations or sizes of pulmonary nodules within the lung.
erefore, in order to train our multi-stage framework, we utilise
an additional dataset, the Lung Nodule Analysis 2016 (LUNA16)
dataset, which provides nodule annotations. is presents its own
problems however, as this dataset does not contain the cancer status
of patients. We thus utilise both datasets to train our framework in
two stages.
2.1.1 LUNA16. e Lung Nodule Analysis 2016 (LUNA16) dataset
is a collection of 888 axial CT scans of patient chest cavities taken
from the LIDC/IDRI database[4], where only scans with a slice
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thickness smaller than 2.5 mm are included. In each scan, the loca-
tion and size of nodules are agreed upon by at least 3 radiologists.
ere is no information regarding the malignancy or benignity of
each nodule or the cancer status of the associated patient.
In total, 1186 nodules are annotated across 601 patients. We use
542 patients as a training set and the remaining 59 as a validation
set. A slice from one patient, with a single nodule location shown,
can be seen in Figure 2.
Figure 2: A slice displaying a cross section of a patient chest
cavity from the LUNA16 dataset, with a nodule annotated.
2.1.2 Kaggle Data Science Bowl 2017. e Kaggle Data Science
Bowl 2017 (KDSB17) dataset is comprised of 2101 axial CT scans of
patient chest cavities. Of the 2101, 1595 were initially released in
stage 1 of the challenge, with 1397 belonging to the training set and
198 belonging to the testing set. e remaining 506 were released
in stage 2 as a nal testing set.
Each CT scan was labelled as ‘with cancer’ if the associated
patient was diagnosed with cancer within 1 year of the scan, and
‘without cancer’ otherwise. Crucially, the location or size of nodules
are not labelled. Figure 3 contains a sample slice from this dataset.
2.1.3 Preprocessing. Each scan is comprised of multiple 2D axial
scans taken in sequence with pixel values in the range (-1024, 3071),
corresponding to Hounseld radiodensity units. e number of
slices, slice thickness, and scale vary between scans.
We normalize pixel values to the (0, 1) range and stack the 2D
slices in sequence to produce a 3D volume. e entire 3D volume is
scaled and padded, while maintaining the true aspect ratio using the
embedded scale information, into a (512 × 512 × 512) volume. Due
to the increased GPU memory usage involved with volumetric data,
we then separate this volume into overlapping (128 × 128 × 128)
crops with a 64 voxel stride, to be processed by our pipeline in
parallel.
Figure 3: A slice displaying a cross section of a patient chest
cavity from the Kaggle Data Science Bowl 2017 dataset. No
annotations of nodule locations or sizes are provided.
2.2 Architecture
Our framework is divided into four separate neural networks. ey
are the:
(1) nodule detector, which accepts a normalized 3D volume
crop from a CT scan and identies areas that contain nod-
ules;
(2) malignancy detector, which operates similarly to the
nodule detector, but further classies nodules as benign
(non-cancerous) or malignant (cancerous);
(3) nodule classier, which accepts individual nodule vol-
umes and similarly classies them as benign or malignant;
and–
(4) patient classier, which accepts features from the malig-
nancy detector and nodule classier and yields the proba-
bility of the patient having cancer.
e nodule detector is used to detect regions that contain nodules.
e malignancy detector provides a class probability map over
grid cells of each cell containing benign, malignant, or no nodules.
Separate code extracts and preprocesses nodule volumes and runs
the classier on each, yielding the probability of malignancy for
each nodule. Finally, the patient classier pools features from the
classier and features from the malignancy detector; producing the
probability of the patient having lung cancer. Figure 4 graphically
shows the structure of our pipeline.
2.2.1 Nodule Detectors. Common frameworks for object detec-
tion (such as Faster RCNN [27]) produce precise bounding boxes
around objects of interest. As our task does not require perfect
localization, we instead divide the search space into a uniform grid
and perform detection in each grid cell. is was inspired by the
class probability map of the YOLO network [26].
We base our architecture on the pre-activation version of ResNet-
101 [14, 15], which uses fewer parameters than other state-of-the-
art networks while achieving comparably high accuracy on visual
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Figure 4: Our framework design. enodule detector is used
to detect and extract nodules for the nodule classier, and is
also used to initialise theweights of themalignancy detector.
e patient classier aggregates results from both networks
and produces the probability of the patient having lung can-
cer.
tasks. Our modied ResNet is described in Table 1. Notably, we
use 3D convolutions and pooling, and replace the global average
pooling operation with a (1 × 1 × 1) convolution. Additionally,
we substitute rectied linear units (ReLU) with Leaky ReLU units
(α = 0.1), to improve convergence.
We interpret the output as a class probability map of nodules oc-
curring inside the corresponding receptive eld. Our modications
also narrow the receptive eld of each output node to (16× 16× 16)
voxels to beer localize nodules as illustrated in Figure 5, which
shows the distribution of nodule radii in the LUNA16 dataset.
A (128 × 128 × 128) input volume produces an (8 × 8 × 8) output
class probability map. e nodule detector provides a distribution
over two classes {‘has-nodule’, ‘no-nodule’}, while the malignancy
detector provides a distribution over three {‘malignant’, ‘benign’,
‘no-nodule’}. An example of the output map can be seen in Figure 6.
e output of the malignant detector is provided directly to
the patient-level classier. It acts as a global feature, providing
information on the distribution of malignant nodules through the
entire volume without providing specic information about any
nodule.
As nodules are sparsely distributed through the scan, we expect
there to be a strong class imbalance. We address this by weighting
our cross-entropy function during training. In the nodule detector,
we balance the loss by calculating a weight per-batch and apply it
to the weaker class as in Equation 1.
Layers Size, Filters Stride Output Size
Convolution 3D 7 × 7 × 7, 64 2 64 × 64 × 64
Max Pool 3D 3 × 3 × 3 2 32 × 32 × 32
Block 1

1 × 1 × 1, 64
3 × 3 × 3, 64
1 × 1 × 1, 256

× 3 2 16 × 16 × 16
Block 2

1 × 1 × 1, 128
3 × 3 × 3, 128
1 × 1 × 1, 512

× 4 2 8 × 8 × 8
Block 3

1 × 1 × 1, 256
3 × 3 × 3, 256
1 × 1 × 1, 1024

× 23 1 8 × 8 × 8
Block 4

1 × 1 × 1, 512
3 × 3 × 3, 512
1 × 1 × 1, 2048

× 3 1 8 × 8 × 8
Convolution 3D 1 × 1 × 1, c 1 8 × 8 × 8
Somax 8 × 8 × 8
Table 1: ResNet-101, modied for nodule detection (with c =
2) and malignancy detection (with c = 3). Notably, we use
3D operations, replace the global average pooling operation
with a (1× 1× 1) convolution, and narrow the receptive eld
of each output node to (16 × 16 × 16) voxels.
Loss(p,q) = − 1|C |
∑
c ∈C
w(c) · p(c) logq(c) (1)
where p is the predicted distribution,
q is the true distribution,
C is {‘no-nodule’, ‘has-nodule’}
fc is the frequency of class c in the mini-batch, and–
w(c) =

fno-nodule
fnodule
if c is nodule
1 otherwise
In the malignancy detector, we slightly alter the loss function
and generalise it to allowing balancing of multiple classes as in
Equation 2. We did not have time to retrain the initial nodule
detector with this generalised loss, but expect similar performance.
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Figure 5: Distribution of nodule radii in the LUNA16 dataset
aer preprocessing.
Figure 6: Output class probability map of the nodule detec-
tor with c = 2.
Loss(p,q) = − 1|C |
∑
c ∈C
1
fc
· p(c) logq(c) (2)
where p is the predicted distribution,
q is the true distribution,
C is {‘malignant’, ‘benign’, ‘no-nodule’}, and–
fc is the frequency of class c in the mini-batch.
2.2.2 Nodule Classifier. Every grid cell reported to contain a
nodule by the nodule detector is extracted from the original volume.
Note that the nodules classier works on the detector output and
not on the malignancy detector one. is allows the framework to
be more robust by ensembling results from the separate networks.
Contiguous grid cells with nodules are assumed to contain parts
of the same nodule, and are stitched together. All nodules are scaled
and zero-padded to t into a (32 × 32 × 32) volume.
e nodule classier takes as input the (32 × 32 × 32) volume
with the nodule and classies it as malignant or benign. As the
size of the input is smaller, training the classier on the detected
nodules is signicantly easier than on the entire scan volume. e
classier is based on the pre-activation version of ResNet-18 and is
described in Table 2.
Layers Size, Filters Stride Output Size
Convolution 3D 7 × 7 × 7, 64 2 16 × 16 × 16
Max Pool 3D 3 × 3 × 3 2 8 × 8 × 8
Block 1

3 × 3 × 3, 64
3 × 3 × 3, 64
 × 2 1 8 × 8 × 8
Block 2

3 × 3 × 3, 128
3 × 3 × 3, 128
 × 2 2 4 × 4 × 4
Block 3

3 × 3 × 3, 256
3 × 3 × 3, 256
 × 2 1 4 × 4 × 4
Block 4

3 × 3 × 3, 512
3 × 3 × 3, 512
 × 2 1 4 × 4 × 4
Average Pool 3D Global 1 × 1 × 1
Fully Connected 2 1
Somax 1
Table 2: ResNet-18, modied for nodule classication. e
strides are lighter than in the original structure, and we use
average pooling at the end.
2.2.3 Patient Classifier. To create a single feature vector for each
patient, the global patient features from the malignancy nodule
detector are combined with the local nodule features from the
nodule classier.
We aggregate the output of the malignancy detector by combin-
ing crops for each patient and constructing a density histogram
over the somax output, with 32 bins for each class in {‘malignant’,
‘benign’, ‘no-nodule’}. e number of crops containing a nodule is
also appended to this feature. We pool the nodule classier outputs
by computing the number of nodules, minimum, maximum, mean,
standard deviation, and sum of the somax output, as well as a 10
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bin density histogram. In the case of a patient without any detected
nodule, all these values are set to zero.
e features from both networks are then weighted and concate-
nated into a 113 dimensional vector. is acts as input to a simple
neural network with two hidden layers followed by ReLU non-
linearity as shown in Table 3. is network produces the two-class
probability of the cancer status of the patient.
e use of histograms to perform pooling in neural networks is
a long-accepted technique, dating to the earliest development of
neural networks[5].
Layers Features Dropout
Fully Connected 1024 0.5
Fully Connected 1024 0.5
Fully Connected 2
Somax
Table 3: Patient Classier with two hidden layers pooling
features from the malignancy detector and nodule classier
into a two-class probability of the cancer status of the pa-
tient.
2.3 Training
2.3.1 Nodule Detector, LUNA16. Each volume crop in LUNA16
is preprocessed then divided into a uniform grid, with each cell of
size (16× 16× 16). If the bounding box of a nodule intersects with a
grid cell, that cell is deemed to be labelled ‘has-nodule’; other cells
are labelled ‘no-nodule’. To save time, we sample only 128 random
crops from each patient for training, duplicating crops with nodules
to maintain class balance.
We train for 100 000 iterations of 24 mini-batches, with a learning
rate of 0.01 and weight decay of 10−4. e Adam optimizer [19] is
used with default parameters of (β1 = 0.9, β2 = 0.999).
2.3.2 Malignancy Detector, KDSB17. is network is initialized
with the weights of the trained nodule detector network, modied
to return a distribution over three classesC = {‘malignant’, ‘benign’,
‘no-nodule’}. We ne-tune this network on the KDSB17 dataset:
cells classied by the nodule detector as ‘has-nodule’ are classied
as ‘malignant’ or ‘benign’ depending on the cancer status of the
patient; other cells are classied as ‘no-nodule’. We only train and
test on crops that contain a nodule and maintain class balance by
duplication. is is an optional step done to save time. We ne-tune
this model, rst for 20 000 iterations with a learning rate of 0.01,
then for 30 000 iterations with a learning rate of 0.001.
2.3.3 Nodule Classifier. Over the KDSB17 dataset, we detect
between 0 and 10 nodule grid cells per scan. We stack and average
detection results from over-lapping crops and consider detections
with a condence above 0.5 as indicating the presence of a nodule.
We then extract all the detected nodules from all the patients, and
scale with zero-padding to a xed value of (32×32×32) for training.
Each of these nodules are classied independently. Generally, in a
patient with cancer, only a few of the nodules present are malignant.
All nodules in patients without cancer are benign.
Figure 7: First row: nodule found in a healthy patient.
Second row: largest nodule found in a patient with cancer.
Size itself cannot distinguish them from healthy ones.
e white zones on the right correspond to lung borders.
Benign and malignant nodules are dicult to distinguish, even
for experienced radiologists; Figure 7 compares sample cross-sections.
Doctors oen use the nodule size as a rst criteria in nodules ex-
amination: cancerous nodules tend to be the largest, and usually
larger than a particular threshold [25].
For the classier, we explore dierent methods of labelling nod-
ules and build the set of malignant nodules using the heuristic
measure described in Section 2.3.5.
Malignant nodules are far less prevalent than benign (around 1
for 7). To rebalance the classes, we augment the set of malignant
nodules by ipping and 90-degree rotations.
We trained from scratch for 6 000 iterations (stopping early)
using the Adam optimizer with a batch size of 32, a learning rate of
0.001, and a weight-decay of 10−4. We split the training data into
an actual training set and a validation one, the laer corresponding
to 10% of original training patients.
2.3.4 Patient Classifier. e patient classier is trained to asso-
ciate the pooled outputs from the malignancy detector and classier
with the cancer status of the patient, as provided in the KDSB17
dataset. We initialise weights as in [13], and train with the Adam
optimizer for 2 000 iterations using a learning rate of 0.001, with all
the data used as a single batch. To prevent overing, we train the
patient classier on an augmented version of the KDSB17 training
set (augmented via volume transpose), and use a weight decay of
10−4. Output is clipped to [0.1, 0.9].
2.3.5 Strategies for Labelling Training Data. To classify individ-
ual nodules we need to obtain labels for each nodule. We do not
have any such data, and obtaining radiologist annotation on individ-
ual nodules was not feasible. We know that all nodules in patients
without cancer are benign; and we use heuristic methods to label
nodules within patients with cancer as benign or malignant:
We compare two dierent heuristic methods to assign labels to
nodules: the patient-label strategy, and the largest-nodule strategy.
e patient-label strategy is the simplest possible, where we label
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all nodules from a patient with cancer as malignant. e largest-
nodule strategy assumes that in patients with cancer, the largest
nodule and all nodules at least some proportion w of that nodule
are malignant. We used the laer in the Kaggle competition.
In contrast, the malignancy detector uses the patient-label heuris-
tic. is is a deliberate simplication to avoid the computational
overhead of backpropagation through the nodule extractor. e
classier does not incur such an overhead because it operates on
nodules aer the extractor has assembled them from grid cells.
3 RESULTS AND DISCUSSION
In medical diagnostics, it is common to present classier perfor-
mance using sensitivity (the true positive rate) and specicity (the
true negative rate) instead of accuracy. To assess overall classica-
tion relevance, we also compute the F1-score. In the KDSB 2017,
candidates were evaluated using the log-loss metric. We evaluate
each component in the entire pipeline and present our results.
3.1 Performance
Rank Team Name Log-Loss
1 grt123 0.39975
2 Julian de Wit & Daniel Hammack 0.40117
3 Aidence 0.40127
41 AIDA (Our Team) 0.52712
50 Excelsior 0.55041
100 rnrq 0.60490
200 Byeong-wooJeon 0.61946
Uniform (0.5) Benchmark 0.69315
Table 4: Ranking Table, 1972 teams in total.
We evaluate the patient classier directly on the stage 1 and
stage 2 test sets of the KDSB17 dataset. On stage 1 test data, we
observe sensitivity of 0.719, specicity of 0.716, and Log-Loss of
0.47707, ranking our entry as 71st during the rst round of the
competition. Sensitivity and specicity are computed by seing the
probability threshold separating the two classes on the classier’s
output at 0.25.
When testing on stage 2 test data in the second phase of the
KDSB17 contest, we observe a Log-Los of 0.52712 ranking our
entry as 41st out of 1972 teams, placing us in the top 3%. As the
competition organizers only reported the log loss, we are unable to
make a direct comparison of approaches. We present our ranking
in Table 4.
During the competition, only 4 features were used from the
nodule classier, number of nodules, mean, std, and sum of the
somax output. Post-competition, we use additional features as
described in Section 2.2.3. We present updated results in Table 5
and compare the overall performance of each component and their
contribution to the nal result.
Sensitivity Specicity F1 Log-Loss
MD + NC 0.667 0.773 0.598 0.475
MD 0.719 0.653 0.558 0.484
NC 0.632 0.582 0.474 0.578
Table 5: Comparing updated performance of the Malig-
nancy Detector (MD), the Nodule Classier (NC), and their
contribution to the nal results when pooling through the
patient classier and evaluating on the KDSB17 stage 1 test
set. A threshold of 0.25 on the output was used to seperate
positive and negative classes.
3.2 Component Training
3.2.1 Nodule &Malignancy Detector. To verify the nodule detec-
tor’s performance, we evaluate on the validation set of LUNA16 and
observe sensitivity of 0.697, specicity of 0.999, and F1-score of
0.740. We similarly evaluate the malignancy detector on the stage
1 test set of KDSB17 and observe sensitivity of 0.317, specicity of
0.997, and F1-score of 0.269. e metrics for the malignancy detec-
tor are calculated with only the malignant nodules as the positive
class.
While the nodule detector performs well, the malignancy detec-
tor has comparatively poor performance. is is likely due to the
additional class increasing the complexity of the task.
Additionally, the malignancy detector is trained on a version
of the KDSB17 dataset where nodules are labelled using a naive
method of labelling all nodules in a cancer patient as malignant.
is naive patient-labelling method might introduce noise into the
groundtruth labels of the annotated dataset, thus impeding the
learning of the network. As labelling of nodules is done by the
nodule detector, errors in labelling also propagate down to the
malignancy detector as well as nodule classier.
3.2.2 Nodule Classifier. We evaluate the classier’s performance
using sensitivity, specicity, as well as F1-score.
Initially training with 10 000 steps resulted in almost perfect
scores while evaluating the model on training data, indicating a
high chance of over-ing. Additionally, the F1-score started to
deteriorate rapidly. To prevent this, we stop training early, before
performance on the training set aens. Table 6 shows the classier
performance on the testing set aer several training durations.
For the nal architecture, we use a model trained for 6 000 steps.
It provides the best trade-o between all three criteria.
e quality of these classication results directly relies on the
quality of the nodules labelling strategy that was used. A strat-
egy that mislabelled many nodules would result in lower classier
performance.
In Table 7 we present the classication results of the patient-label
strategy and the largest-nodule strategy (see Section 2.3.5. ) with
w = 90% and w = 70% when applied to the classier, trained for
6 000 steps.
Largest nodule with w = 70% gives an average F1-score and the
best trade-o between specicity and sensitivity. is suggests it
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Sensitivity Specicity F1
4k training steps 0.385 0.830 0.347
6k training steps 0.538 0.638 0.33
10k training steps 0.738 0.368 0.306
Table 6: Nodules classication results aer dierent train-
ing lengths. ese results are obtained on the stage 1 test
set. In each case, the best threshold to separate the positive
class from the negative one is found on the validation set,
and equals to 0.5, 0.45, and 0.8 respectively.
Sensitivity Specicity F1
Patient-label 0.762 0.180 0.434
Largest (w = 90%) 0.250 0.856 0.254
Largest (w = 70%) 0.538 0.648 0.33
Table 7: Nodules classication results on stage 1 test set with
dierent ways of labeling nodules. Refer to part 2.3.2 for
the explanations related to these dierent methods. In each
case, the best threshold to separate the positive class from
the negative one is found on the validation set, and equals
to 0.5, 0.55, and 0.45 respectively.
is the method leading to the least number of mislabelled training
nodules. Cancerous nodules are usually the largest ones, and not
all nodules are systematically malignant. In our pipeline, we thus
use the largest-nodule strategy (w = 70%) for the classier.
Changing the strides in the ResNet architecture is essential. With
the original stride values from the ResNet-18 architecture, train-
ing is less ecient. Convolutional lters become larger than the
convolutional feature maps, harming learning and leading to very
poor sensitivity and F1-score. In consequence, strides are removed
in blocks 1, 2 and 4. Table 8 shows the classier performance on
the testing set aer 6 000 training steps.
Sensitivity Specicity F1
Original ResNet 0.169 0.858 0.181
Our architecture 0.538 0.648 0.33
Table 8: Nodules classication results obtained on the stage
1 test set. We compare results between an original ResNet
architecture and the stridesmodication that we applied. In
both cases, the best threshold to separate the positive class
from the negative one is found on the validation set, and
equals to 0.5 and 0.45 respectively.
4 CONCLUSIONS AND FUTUREWORK
Detecting lung cancer in a full 3D CT-Scan is a challenging task.
Directly training a single-stage network is futile, but factoring
our solution into multiple stages makes training tractable. Due to
imperfect datasets, our approach leveraged the LUNA16 dataset
to train a nodule detector, and then rened that detector with the
KDSB17 dataset to provide global features. We use that, and pool
local features from a separate nodule classier, to detect lung cancer
with high accuracy.
e quality of our method was validated by the competition, in
which we placed 41st out of 1972 teams (top 3%).
4.1 Improvements
ere are many ways in which we can extend our method:
Our method makes lile use of the peculiarities of cancer nodules,
and so will likely improve with advice from medical professionals.
de Wit [7], who placed second in the competition, used 17 dierent
CNNs to extract the diameter, lobulation, spiculation, calcication,
sphericity, and other features of nodules. ese features are com-
monly used to classify nodules [4], and help the network beer
learn about malignancy and cancers.
When ne-tuning the nodule classier, we rely on heuristic
methods to determine which nodules are malignant and which are
benign. ese heuristic methods have not been experimentally
validated, and so remain of dubious quality. We can instead ap-
ply unsupervised learning techniques together with a small set of
radiologist-labelled nodules to directly learn the dierence between
malignant and benign nodules.
4.2 Future Work
e generality of our method also suggests that it can be adapted
to other tumour- and cancer diagnosis problems. e design of our
pipeline does not rely on any particular feature of lungs or lung
cancer, and so we can easily adapt our pipeline to other nodular
cancers, or perhaps other diseases.
We have many more negative examples than positive examples,
and so we need to balance our classes to improve classication
performance. Current balancing techniques rely on classical data
augmentation (ipping, rotation, etc.), though we would like to
investigate advanced techniques such as 3D Generative Adversarial
Networks (3D GANs) [33]. GANs are a relatively novel invention,
and such a fusion technique may yield insight into both GANs and
lung cancer.
Radiologists do not arrive at a diagnosis of lung cancer from a
single CT scan [25]. ey diagnose a particular type of lung cancer
using a sequence of CT scans over a few months. ey match the
behaviour of the nodules over time with a particular subtype of lung
cancer. To match radiologist-level accuracy on the task, we need to
develop a time-varying model of lung cancer that can eectively
include a progression of CT scans.
Patient-level priors also signicantly aect diagnoses. Age, sex,
smoking behaviour, familial co-occurrence, occupation, etc. are
all factors that inuence the likelihood of developing lung cancer.
Adding this heterogeneous data will yield signicant improvement
in detection performance.
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From a clinical perspective, detecting the subtype and optimiz-
ing treatment options is a vitally important problem that machine
learning can tackle. Our long-term goal is to model the disease
itself, so that we can detect it, predict its behaviour, and treat it
optimally.
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